Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research at AdventHealth Central Florida, Professor of Medicine at the University of Central Florida, and at Loma Linda University Health, shared a post on LinkedIn:
“Bladder cancer webinar – honored to participate as speaker from AdventHealth Central Florida Cancer Institute – sponsored by Dr. Vishwanath Sathyanarayanan, CPOEM Foundation – along with a great speaker lineup including Daniel Petrylak, Dr. Ashwin Mallya, we discuss cutting-edge and emerging therapies reported at ASCO25 and GU25 – look for exciting data at ESMO25.”
More posts featuring Guru Sonpavde.